These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 34958036
1. Functional Neural Correlates of Semantic Fluency Task Performance in Mild Cognitive Impairment and Alzheimer's Disease: An FDG-PET Study. Ahn H, Yi D, Chu K, Joung H, Lee Y, Jung G, Sung K, Han D, Lee JH, Byun MS, Lee DY. J Alzheimers Dis; 2022; 85(4):1689-1700. PubMed ID: 34958036 [Abstract] [Full Text] [Related]
2. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis. Khosravi M, Peter J, Wintering NA, Serruya M, Shamchi SP, Werner TJ, Alavi A, Newberg AB. J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568 [Abstract] [Full Text] [Related]
3. [Comparative characteristics of neuropsychological and neurometabolic changes in patients with Alzheimer's disease and vascular cognitive impairment]. Emelin AY, Odinak MM, Lobzin VY, Kolmakova KA. Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4. Vyp. 2):17-24. PubMed ID: 38696147 [Abstract] [Full Text] [Related]
4. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD). Bauckneht M, Chincarini A, Piva R, Arnaldi D, Girtler N, Massa F, Pardini M, Grazzini M, Efeturk H, Pagani M, Sambuceti G, Nobili F, Morbelli S. Alzheimers Res Ther; 2018 Apr 03; 10(1):35. PubMed ID: 29615111 [Abstract] [Full Text] [Related]
5. Lexical factors and cerebral regions influencing verbal fluency performance in MCI. Clark DG, Wadley VG, Kapur P, DeRamus TP, Singletary B, Nicholas AP, Blanton PD, Lokken K, Deshpande H, Marson D, Deutsch G. Neuropsychologia; 2014 Feb 03; 54():98-111. PubMed ID: 24384308 [Abstract] [Full Text] [Related]
7. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18. Zahn R, Juengling F, Bubrowski P, Jost E, Dykierek P, Talazko J, Huell M. Psychiatry Res; 2004 Dec 15; 132(2):159-72. PubMed ID: 15598550 [Abstract] [Full Text] [Related]
8. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Knopman DS, Jack CR, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC. Neurobiol Aging; 2014 Sep 15; 35(9):2096-106. PubMed ID: 24702820 [Abstract] [Full Text] [Related]
9. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment. Wang Y, Lou F, Li Y, Liu F, Wang Y, Cai L, Gordon ML, Zhang Y, Zhang N. Curr Alzheimer Res; 2021 Sep 15; 18(6):523-532. PubMed ID: 34598664 [Abstract] [Full Text] [Related]
10. Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data. Sörensen A, Blazhenets G, Rücker G, Schiller F, Meyer PT, Frings L, Alzheimer's Disease Neuroimaging Initiative. Neuroimage Clin; 2019 Sep 15; 21():101637. PubMed ID: 30553760 [Abstract] [Full Text] [Related]
11. Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer's Disease: Clues from [18F]FDG PET Voxel-Wise Analysis. Kreshpa W, Raffa S, Girtler N, Brugnolo A, Mattioli P, Orso B, Calizzano F, Arnaldi D, Peira E, Chincarini A, Tagliafico L, Monacelli F, Calcagno P, Serafini G, Gotta F, Mandich P, Pretta S, Del Sette M, Sofia L, Sambuceti G, Morbelli S, Schenone A, Massa F, Pardini M, Dementia Disease Management Team of the IRCCS Ospedale Policlinico San Martino, Genoa
. J Alzheimers Dis; 2024 Sep 15; 101(2):475-485. PubMed ID: 39240639 [Abstract] [Full Text] [Related]
12. Functional neural correlates of figure copy and recall task performances in cognitively impaired individuals: an 18F-FDG-PET study. Han JY, Byun MS, Seo EH, Yi D, Choe YM, Sohn BK, Choi HJ, Baek H, Lee JH, Kim HJ, Woo JI, Lee DY. Neuroreport; 2015 Dec 02; 26(17):1077-82. PubMed ID: 26509549 [Abstract] [Full Text] [Related]
13. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism. Smailovic U, Koenig T, Savitcheva I, Chiotis K, Nordberg A, Blennow K, Winblad B, Jelic V. Brain Connect; 2020 Dec 02; 10(10):555-565. PubMed ID: 33073602 [Abstract] [Full Text] [Related]
14. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism. Gerretsen P, Chung JK, Shah P, Plitman E, Iwata Y, Caravaggio F, Nakajima S, Pollock BG, Graff-Guerrero A, Alzheimer’s Disease Neuroimaging Initiative. J Clin Psychiatry; 2017 Dec 02; 78(9):e1187-e1196. PubMed ID: 29022655 [Abstract] [Full Text] [Related]
15. Functional Neural Correlates of the WAIS-IV Block Design Test in Older Adult with Mild Cognitive Impairment and Alzheimer's Disease. Joung H, Yi D, Byun MS, Lee JH, Lee Y, Ahn H, Lee DY. Neuroscience; 2021 May 21; 463():197-203. PubMed ID: 33865943 [Abstract] [Full Text] [Related]
16. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease. Schönknecht OD, Hunt A, Toro P, Guenther T, Henze M, Haberkorn U, Schröder J. Clin EEG Neurosci; 2011 Apr 21; 42(2):71-6. PubMed ID: 21675596 [Abstract] [Full Text] [Related]
17. Design and Verbal Fluency in Alzheimer's Disease and Frontotemporal Dementia: Clinical and Metabolic Correlates. Delgado-Álvarez A, Cabrera-Martín MN, Pytel V, Delgado-Alonso C, Matías-Guiu J, Matias-Guiu JA. J Int Neuropsychol Soc; 2022 Oct 21; 28(9):947-962. PubMed ID: 34569460 [Abstract] [Full Text] [Related]
18. The functional neuroanatomy of verbal memory in Alzheimer's disease: [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory. Staffaroni AM, Melrose RJ, Leskin LP, Riskin-Jones H, Harwood D, Mandelkern M, Sultzer DL. J Clin Exp Neuropsychol; 2017 Sep 21; 39(7):682-693. PubMed ID: 27876444 [Abstract] [Full Text] [Related]
19. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI. Ben Bouallègue F, Mariano-Goulart D, Payoux P, Alzheimer’s Disease Neuroimaging Initiative (ADNI). J Alzheimers Dis; 2018 Sep 21; 62(1):399-408. PubMed ID: 29439345 [Abstract] [Full Text] [Related]
20. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Am J Psychiatry; 2002 May 21; 159(5):738-45. PubMed ID: 11986126 [Abstract] [Full Text] [Related] Page: [Next] [New Search]